Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Furha I. Cossor, MD, Sandy Wong, MD, Kenneth B Miller, MD, Deborah Black, RN, Raymond L. Comenzo, MD, Andreas K. Klein, MD, Alanna Klekar, RN, Valerie Relias, PharmD, Hedy Smith, MD, PhD, Kellie Sprague, MD, Karen M Switkowski, MS, MPH, Richard A. Van Etten, MD PhD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4153.

https://doi.org/10.1182/blood.V118.21.4153.4153

Published: 2011

Journal Articles

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Deepa Jeyakumar, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Andreas K. Klein, MD, Hans-Georg Klingemann, MD, PhD

Blood (2011) 118 (21): 4506.

https://doi.org/10.1182/blood.V118.21.4506.4506

Published: 2011

Journal Articles

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Hans-Georg Klingemann, MD, PhD, Carrie Grodman, RN, Andreas K. Klein, MD, Kellie Sprague, MD, Kenneth B. Miller, MD, Tarun Kewalramani, MD, Raymond L. Comenzo, MD, Neng Yu, MD, Marvin Duque, MD, Richard A. Van Etten, MD, PhD, David McKenna, MD

Blood (2010) 116 (21): 4299.

https://doi.org/10.1182/blood.V116.21.4299.4299

Published: 2010

Journal Articles

Transfection of NK Cells with mRNA or Lentivirus Expressing Chimeric Antigen Receptors Results in Highly Efficient Killing of Lymphoid Malignancies and Compares Favorably with Monoclonal Antibody-Directed ADCC.

Laurent Boissel, PhD, Monica Betancur, MSc, Richard A. Van Etten, MD, PhD, Hans-Georg Klingemann, MD, PhD

Blood (2009) 114 (22): 1696.

https://doi.org/10.1182/blood.V114.22.1696.1696

Published: 2009

Journal Articles

Co-Transplantation of Autologous Umbilical Cord Matrix Mesenchymal Stem Cells Improves Engraftment of Umbilical Cord Blood in NOD/SCID Mice.

Robb Friedman, MD, Monica Betancur, MS, Hande Tuncer, MD, Laurent Boissel, PhD, Curtis Cetrulo, MD, Hans-Georg Klingemann, MD/PhD

Blood (2006) 108 (11): 2569.

https://doi.org/10.1182/blood.V108.11.2569.2569

Published: 2006

Journal Articles

A Novel Anti CD23 Fully Human Monoclonal Antibody Potentially Useful for B-CLL Therapy.

Marc Delcommenne, PhD, Hans-Georg Klingemann, MD, PhD, Stephanie A. Gregory, MD

Blood (2005) 106 (11): 5047.

https://doi.org/10.1182/blood.V106.11.5047.5047

Published: 2005

NARROW

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Transfection of NK Cells with mRNA or Lentivirus Expressing Chimeric Antigen Receptors Results in Highly Efficient Killing of Lymphoid Malignancies and Compares Favorably with Monoclonal Antibody-Directed ADCC.

Co-Transplantation of Autologous Umbilical Cord Matrix Mesenchymal Stem Cells Improves Engraftment of Umbilical Cord Blood in NOD/SCID Mice.

A Novel Anti CD23 Fully Human Monoclonal Antibody Potentially Useful for B-CLL Therapy.

Email alerts

ASH Publications

American Society of Hematology

Outcomes in Allogeneic Hematopoietic Stem Cell Transplant Patients ≥ 60 Years of Age with a Novel Reduced Intensity Conditioning Regimen Incorporating Extracorporeal Photopheresis,

Clofarabine for Cytoreduction Prior to Allogeneic Transplant Conditioning for Refractory Acute Myelogenous Leukemia

Allogeneic NK Cell Therapy After Autologous Stem Cell Transplant: Results of a Phase I Study

Transfection of NK Cells with mRNA or Lentivirus Expressing Chimeric Antigen Receptors Results in Highly Efficient Killing of Lymphoid Malignancies and Compares Favorably with Monoclonal Antibody-Directed ADCC.

Co-Transplantation of Autologous Umbilical Cord Matrix Mesenchymal Stem Cells Improves Engraftment of Umbilical Cord Blood in NOD/SCID Mice.

A Novel Anti CD23 Fully Human Monoclonal Antibody Potentially Useful for B-CLL Therapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only